Pfizer, Bioentech, Moderna make ડો 1,000 a second in Corona's time

The total number of corona cases in the world is 25,47,88,242, death toll 51,26,088

US Corona Travel Advisory Level Four Signs of Improvement in India

280 materials are procured from 19 countries to make Pfizer corona vaccine

NEW YORK: Three pharma companies, Pfizer, Bioentech and Modern, which invented the corona vaccine, have made a profit of 1,000 1,000 per second through their corona vaccine at a difficult time when the world has been facing a corona epidemic for the past two years and the economies of many countries are crumbling.

The world's poorest countries, on the other hand, are still deprived of vaccinations and millions are dying. The three companies have sold most of their vaccines to rich countries, resulting in an annual profit of 34 34 billion, or more than 1,000 1,000 per second, or 65 65,000 a day, or 9. 93.5 million a day.

On the other hand, the total number of corona cases in the world has risen to 254,788,242 with 2,17,795 new cases being reported while 4191 deaths have resulted in 51,26,088 corona deaths.

A total of 7,492,843,205 doses of the corona vaccine were given worldwide. A total of 48,072,898 cases were reported in the US, with 70,823 new cases of corona reported and 467 deaths, bringing the total number of corona deaths to 7,84,779, according to the WorldDometer website.

Other countries with more than 6 million cases of corona include Brazil 2,19,60,766 UK 96,49,233, Russia 89,56,136, Turkey 84,33,988, France 73,93,296 and Iran 60,45,212.

However, the improvement in Corona's condition in India is indicated by a travel advisory issued by the US CDC. This year's Akambe was an advisory four in which US citizens were barred from traveling to India. An advisory level two was released in August stating that Corona's risk was moderate.

Advisory Level One has now been released which states that those who have been vaccinated against corona have a lower risk of contracting corona. On the other hand, two dignitaries of the world have come up against this in the case of Corona vaccine, a weapon to fight the Corona epidemic.

World Health Organization (WHO) Secretary-General Tedros Ghebreyes said at a virtual meeting held in July that there was a shocking imbalance in vaccine distribution, adding that it was unacceptable for vaccine manufacturers to charge rich countries the highest price for corona vaccine.

In the presence of half a dozen people who were listening to this, Ghebraces told Pfizer's CEO that "I honestly don't think I get any of the promises I expect from you."

In response, Pfizer CEO Albert Borula said the Tedros were speaking out in a stream of emotions. However, the CEO of Pfizer did not say a word about the Corona vaccine formula. More than 280 materials are procured from suppliers in 19 countries to make Pfizer corona vaccines.

However, Pfizer has allowed a UN-backed group of manufacturers to develop an experimental pill to treat corona. It is estimated that half of the world's population will benefit from corona treatment. Pfizer said in a statement that it would license generic drug companies to manufacture the antiviral pill, which could be manufactured in 95 countries.

However, the deal excludes countries such as Brazil, where Corona has wreaked havoc. The stipulation is that the Brazilian company could produce the pill for export, but not for generic production in Brazil. Health officials believe Pfizer's deal will help bring an early end to the epidemic.

Under the terms of the deal, Pfizer will lose royalties to low-income countries. Earlier this month, Pfizer said its corona pill reduces the risk of hospitalization and death by 90 percent.

Corona is currently being treated by injection in most countries of the world. Britain approved Merck's Corona tablet earlier this month, but it has yet to be approved elsewhere. In one such deal, Merck allowed other drug manufacturers to manufacture Corona pill Molnupiravar so that it could be made available in 105 poorer countries.